We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

136 hedge funds and large institutions have $465M invested in Cytokinetics in 2017 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 53 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 13

123% more call options, than puts

Call options by funds: $5.24M | Put options by funds: $2.35M

96% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 27

27% more capital invested

Capital invested by funds: $366M → $465M (+$98.8M)

26% more funds holding

Funds holding: 108 → 136 (+28)

10.64% more ownership

Funds ownership: 68.21% → 78.84% (+11%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
136
Holders Change
+28
Holders Change %
+25.93%
% of All Funds
3.39%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
41
Increased
53
Reduced
27
Closed
13
Calls
$5.24M
Puts
$2.35M
Net Calls
+$2.89M
Net Calls Change
-$812K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$44.6M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$37.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$17.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$16.2M
5
State Street
State Street
Massachusetts
+$10.3M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$31.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$14.3M
3
WA
Wasatch Advisors
Utah
-$10.1M
4
Millennium Management
Millennium Management
New York
-$5.04M
5
HCMT
Highland Capital Management (Texas)
Texas
-$2.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
51
Nationwide Fund Advisors
Ohio
$804K +$654K +47,080 +243%
Canada Life
52
Canada Life
Manitoba, Canada
$804K +$927K +66,700 New
SIM
53
Spark Investment Management
New York
$755K -$45.9K -3,300 -5%
Swiss National Bank
54
Swiss National Bank
Switzerland
$697K +$800K +57,600 New
Comerica Bank
55
Comerica Bank
Texas
$689K +$665K +47,862 New
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$635K +$176K +12,699 +32%
SCM
57
Sterling Capital Management
North Carolina
$634K +$728K +52,388 New
Ohio Public Employees Retirement System (OPERS)
58
Ohio Public Employees Retirement System (OPERS)
Ohio
$618K – – –
MCM
59
Moore Capital Management
New York
$605K +$695K +50,000 New
EIM
60
Essex Investment Management
Massachusetts
$563K +$243K +17,510 +60%
CS
61
Credit Suisse
Switzerland
$537K +$198K +14,244 +47%
AllianceBernstein
62
AllianceBernstein
Tennessee
$530K +$240K +17,300 +65%
SAM
63
Shell Asset Management
Netherlands
$519K – – –
Millennium Management
64
Millennium Management
New York
$504K -$5.04M -362,789 -90%
SCM
65
Stevens Capital Management
Pennsylvania
$495K +$569K +40,924 New
PCM
66
Piermont Capital Management
Missouri
$489K -$100K -7,200 -15%
State of Tennessee, Department of Treasury
67
State of Tennessee, Department of Treasury
Tennessee
$489K +$561K +40,380 New
Two Sigma Advisers
68
Two Sigma Advisers
New York
$456K -$38.9K -2,800 -7%
FRM
69
Fox Run Management
Connecticut
$436K +$500K +36,000 New
Wells Fargo
70
Wells Fargo
California
$411K -$74.2K -5,340 -14%
TPSF
71
Texas Permanent School Fund
Texas
$409K +$469K +33,762 New
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$395K +$76.3K +5,490 +20%
Jacobs Levy Equity Management
73
Jacobs Levy Equity Management
New Jersey
$393K +$451K +32,464 New
AIG
74
American International Group
New York
$384K +$151K +10,859 +52%
AQR Capital Management
75
AQR Capital Management
Connecticut
$370K +$82.5K +5,937 +24%
1 2
3
4 5

CYTK Hedge Fund Activity: Q2 2017 in Review

136 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q2 2017, worth a combined $465M — up 27% from $366M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new CYTK positions and 13 closed out — a net gain of 28 holders — while 53 added to existing stakes and 27 trimmed.

The largest buyer was BlackRock, adding an estimated $44.6M. The largest seller was BVF Inc, cutting an estimated $31.6M.

  • 136 institutional investors held Cytokinetics (CYTK) as of Q2 2017, up from 108 in Q1 2017.
  • Funds reported $465M of Cytokinetics stock for Q2 2017, up 27% quarter-over-quarter.
  • 41 funds opened new Cytokinetics positions in Q2 2017 and 13 closed out, a net change of +28 holders.
  • The largest Cytokinetics buyer in Q2 2017 was BlackRock, an estimated $44.6M added.
  • The largest Cytokinetics seller in Q2 2017 was BVF Inc, an estimated $31.6M sold.

Based on aggregated 13F filings for Q2 2017.